Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexicon Pharmaceuticals (LXRX) Invested Capital: 2009-2012

Historic Invested Capital for Lexicon Pharmaceuticals (LXRX) over the last 4 years, with Sep 2012 value amounting to $254.3 million.

  • Lexicon Pharmaceuticals' Invested Capital rose 48.81% to $254.3 million in Q3 2012 from the same period last year, while for Sep 2012 it was $254.3 million, marking a year-over-year increase of 48.81%. This contributed to the annual value of $299.0 million for FY2011, which is 67.55% down from last year.
  • Latest data reveals that Lexicon Pharmaceuticals reported Invested Capital of $254.3 million as of Q3 2012, which was up 3.20% from $246.4 million recorded in Q2 2012.
  • In the past 5 years, Lexicon Pharmaceuticals' Invested Capital ranged from a high of $953.1 million in Q1 2010 and a low of $170.9 million during Q3 2011.
  • For the 3-year period, Lexicon Pharmaceuticals' Invested Capital averaged around $492.4 million, with its median value being $270.4 million (2012).
  • As far as peak fluctuations go, Lexicon Pharmaceuticals' Invested Capital crashed by 81.43% in 2011, and later spiked by 48.81% in 2012.
  • Over the past 4 years, Lexicon Pharmaceuticals' Invested Capital (Quarterly) stood at $772.4 million in 2009, then crashed by 67.87% to $248.2 million in 2010, then grew by 20.49% to $299.0 million in 2011, then surged by 48.81% to $254.3 million in 2012.
  • Its Invested Capital was $254.3 million in Q3 2012, compared to $246.4 million in Q2 2012 and $270.4 million in Q1 2012.